ACSL4 and Parkinson disease: Inhibiting miR-494-3p or ferrostatin-1 dramatically downregulated ACSL4, and overexpression of miR-494-3p observably upregulated ACSL4 in the MPTP-induced PD model mice (Figure 7(d)).